Salivary levels of azurocidin and soluble azurophilic granules in periodontal disease
Journal of Medicine and Life · 2024
DOI: 10.25122/jml-2023-0286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicine and Life, 2024. Verfasst von Fatima Sabah Jasim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Science of Oral Microbiology, College of Dentistry, University of Baghdad, Baghdad, Iraq. Hauptthemen laut MEDLINE: Saliva, Biomarkers, Periodontal Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Periodontitis is an infection-driven inflammatory condition of the periodontium. Neutrophils are one of the most important first-line immune cells that protect against pathogen microorganisms in the saliva, but they may also mediate tissue death in inflammatory disorders. The aim of our study was to estimate salivary levels of azurocidin and extracellular azurophilic granules cluster of differentiation (CD63) as biomarkers of neutrophil activation in patients with periodontal diseases and to study the correlation between the levels of these two biomarkers and clinical periodontal parameters. The study included 60 patients with periodontal disease (30 patients with periodontitis and 30 with gingivitis) and 25 healthy controls. The assessed parameters were bleeding on probing, the plaque index, clinical attachment loss, and probing pocket depth. Saliva samples were taken from each study participant, and azurocidin and CD63 levels were measured using ELISA. Azurocidin and CD63 levels were significantly higher in patients with periodontitis and patients with gingivitis than in controls (P < 0.05), and significantly higher in patients with periodontitis than in patients with gingivitis (P < 0.05). Moreover, we found a significant positive correlation between the two biomarkers with clinical attachment loss in the periodontitis group. This study has shown that increased salivary azurocidin and extracellular CD63 levels are associated with enhanced innate response in periodontal disease and can be considered biomarkers of neutrophil activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Science of Oral Microbiology, College of Dentistry, University of Baghdad, Baghdad, Iraq.
- Department of Basic Science, College of Dentistry, University of Baghdad, Baghdad, Iraq.
- Department of Periodontics, College of Dentistry, University of Baghdad, Baghdad, Iraq.
Zitieren
APA
Jasim, F. S., Al-Ghurabi, B. H., & Abdulameer, L. A. (2024). Salivary levels of azurocidin and soluble azurophilic granules in periodontal disease. Journal of Medicine and Life. https://doi.org/10.25122/jml-2023-0286
Vancouver
Jasim FS, Al-Ghurabi BH, Abdulameer LA. Salivary levels of azurocidin and soluble azurophilic granules in periodontal disease. Journal of Medicine and Life. 2024. doi:10.25122/jml-2023-0286
BibTeX
@article{Jasim2024,
author = {Jasim, Fatima Sabah and Al-Ghurabi, Batool Hassan and Abdulameer, Lubaba Abdulsamad},
title = {Salivary levels of azurocidin and soluble azurophilic granules in periodontal disease},
journal = {Journal of Medicine and Life},
year = {2024},
doi = {10.25122/jml-2023-0286}
}
EUVIMED